Literature DB >> 1531836

Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats.

A Sidhu1, P Vachvanichsanong, P A Jose, R A Felder.   

Abstract

The natriuretic effect of dopamine-1 (DA-1) agonists is reduced in spontaneously hypertensive rat (SHR), partly because of defective DA-1 receptor-adenylate cyclase (AC) coupling in renal proximal convoluted tubules. To investigate this defective coupling, DA-1 dopamine receptors from renal proximal tubules were solubilized and reconstituted into phospholipid vesicles. The binding of DA-1-selective ligand [125I]SCH 23982 was specific and saturable, with no differences in receptor density or Kd between SHR and normotensive rats (Wistar-Kyoto rats; WKY). Competition experiments of the reconstituted DA-1 dopamine receptors in WKY with a DA-1-selective agonist, SKF R-38393, revealed the presence of high- (Kh = 350 +/- 209 nM) and low-affinity (Kl = 70,500 +/- 39,500 nM) binding sites. 100 microM Gpp(NH)p abolished the agonist high-affinity sites, converting them to a low-affinity state (Ki = 33,650 +/- 10,850 nM). In SHR, one affinity site was noted (Ki = 13,800 +/- 500) and was not modulated by Gpp(NH)p (Ki = 11,505 +/- 2,295). The absence of guanine nucleotide-sensitive agonist high-affinity sites may explain the defective DA-1/AC coupling mechanism in the SHR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531836      PMCID: PMC442923          DOI: 10.1172/JCI115657

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Comparison of the central and renal dopamine-1 receptor.

Authors:  A Sidhu; R A Felder; P A Jose; P H Fishman
Journal:  Am J Hypertens       Date:  1990-06       Impact factor: 2.689

3.  Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat.

Authors:  S Kinoshita; A Sidhu; R A Felder
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  An iodinated ligand identifying the D-1 dopamine receptor.

Authors:  A Sidhu; J W Kebabian
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

5.  Solubilization of the D-1 dopamine receptor from rat striatum.

Authors:  A Sidhu; P H Fishman
Journal:  Biochem Biophys Res Commun       Date:  1986-06-30       Impact factor: 3.575

Review 6.  Dopamine receptor subtypes: beyond the D1/D2 classification.

Authors:  P H Andersen; J A Gingrich; M D Bates; A Dearry; P Falardeau; S E Senogles; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

7.  Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes.

Authors:  C C Felder; M Blecher; P A Jose
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

8.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.

Authors:  R K Sunahara; H B Niznik; D M Weiner; T M Stormann; M R Brann; J L Kennedy; J E Gelernter; R Rozmahel; Y L Yang; Y Israel
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

9.  Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's disease.

Authors:  J De Keyser; J P De Backer; G Ebinger; G Vauquelin
Journal:  Brain Res       Date:  1989-09-04       Impact factor: 3.252

10.  Solubilization and reconstitution of the D-1 dopamine receptor: potentiation of the agonist high-affinity state of the receptor.

Authors:  A Sidhu
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

View more
  7 in total

Review 1.  Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.

Authors:  Valeria Rudomanova; Burns C Blaxall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-25       Impact factor: 5.187

2.  Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule.

Authors:  H F Cheng; B N Becker; R C Harris
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.

Authors:  Fadia A Kamal; Joshua G Travers; Allison E Schafer; Qing Ma; Prasad Devarajan; Burns C Blaxall
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

4.  Inflammation compromises renal dopamine D1 receptor function in rats.

Authors:  Mohammad Asghar; Gaurav Chugh; Mustafa F Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-30

Review 5.  Dopaminergic defect in hypertension.

Authors:  P A Jose; G M Eisner; R A Felder
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

6.  A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1 -48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients.

Authors:  Ersilia Cipolletta; Michele Ciccarelli; Raffaele Izzo; Rosa Finelli; Bruno Trimarco; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2012-01-18

7.  Unusually persistent Gαi-signaling of the neuropeptide Y2 receptor depletes cellular Gi/o pools and leads to a Gi-refractory state.

Authors:  Isabelle Ziffert; Anette Kaiser; Stefanie Babilon; Karin Mörl; Annette G Beck-Sickinger
Journal:  Cell Commun Signal       Date:  2020-03-30       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.